Skip to main content

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis

Recovery setup

SellVALUE-TRAP 2/5Moderate Confidence

Healthcare · Medical Care Facilities

Sell if holding. At $7.55, A.R:R 0.9:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 6.2): -1.5; Value-trap signals (2/5): High leverage (D/E 6.2), Material insider selling (10 sells, 0.24% of cap).

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost... Read more

$7.55+13.5% A.UpsideScore 6.1/10#1 of 27 Medical Care Facilities
QualityF-score6 / 9FCF yield4.92%
Stop $7.10Target $8.66(analyst − 13%)A.R:R 0.9:1
Analyst target$9.95+31.8%10 analysts
$8.66our TP
$7.55price
$9.95mean
$13

Sell if holding. At $7.55, A.R:R 0.9:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 6.2): -1.5; Value-trap signals (2/5): High leverage (D/E 6.2), Material insider selling (10 sells, 0.24% of cap). Chart setup: Death cross but MACD improving, RSI 72. Score 6.1/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news boost analyst 0.70, earnings proximity 78d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

Recent Developments — Aveanna Healthcare Holdings Inc

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (4/4)
Attractive valuation
Risks
Leverage penalty (D/E 6.2): -1.5
Value-trap signals (2/5): High leverage (D/E 6.2), Material insider selling (10 sells, 0.24% of cap)

Key Metrics

P/E (TTM)6.4
P/E (Fwd)10.4
Mkt Cap$1.7B
EV/EBITDA9.6
Profit Mgn10.4%
ROE368.0%
Rev Growth15.9%
Beta1.93
DividendNone
Rating analysts17

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C0.40bullish
IV76%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.3
Support Resistance
2.6
52w Position
4.8
GatesA.R:R 0.9 < 1.5@spotMomentum 6.3>=5.5Insider activity: OKNo SEC red flagsNEWS BOOST ANALYST 0.70EARNINGS PROXIMITY 78d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
72 · Overbought
20D MA 50D MA 200D MADEATH CROSSSupport $6.28Resistance $8.11

Price Targets

$7
$9
A.Upside+14.7%
A.R:R0.9:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Reward/Risk 0.9:1 at current price — below 1.5:1 minimum

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-08-06 (78d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AVAH stock a buy right now?

Sell if holding. At $7.55, A.R:R 0.9:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 6.2): -1.5; Value-trap signals (2/5): High leverage (D/E 6.2), Material insider selling (10 sells, 0.24% of cap). Chart setup: Death cross but MACD improving, RSI 72. Prior stop was $7.10. Score 6.1/10, moderate confidence.

What is the AVAH stock price target?

Take-profit target: $8.66 (+13.5% upside). Prior stop was $7.10. Stop-loss: $7.10.

What are the risks of investing in AVAH?

Leverage penalty (D/E 6.2): -1.5; Value-trap signals (2/5): High leverage (D/E 6.2), Material insider selling (10 sells, 0.24% of cap).

Is AVAH overvalued or undervalued?

Aveanna Healthcare Holdings Inc trades at a P/E of 6.4 (forward 10.4). TrendMatrix value score: 8.5/10. Verdict: Sell.

What do analysts say about AVAH?

17 analysts cover AVAH with a consensus score of 3.9/5. Average price target: $10.

What does Aveanna Healthcare Holdings Inc do?Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare...

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Related stocks: ASTH (Astrana Health Inc.) · THC (Tenet Healthcare Corporation) · CON (Concentra Group Holdings Parent) · UHS (Universal Health Services, Inc.) · EHC (Encompass Health Corporation)